机器学习方法用于在社区获得的肺炎儿童中对阿齐思罗米的剂量个性化
Bo-Hao Tang1, Shu-Meng Fu2, Li-Yuan Tian3
1Department of Pharmacy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
机器学习模型可以预测患有肺炎的儿童的亚齐胺暴露 (AUC0-24). 这允许在治疗前和初始度测量后进行个性化剂量,提高治疗的准确性.
科学领域:
- 药理动力学和药理动力学
- 儿童传染病 儿童传染病
- 机器学习在医学中的应用
背景情况:
- 在社区获得性肺炎的儿童中,阿齐思罗米辛的剂量缺乏个性化的精度.
- 阿齐思罗米的疗效与24小时内血度-时间曲线下的面积相关 (AUC0-24).
研究的目的:
- 评估机器学习 (ML) 模型在儿科肺炎患者中预测亚齐胺AUC0-24的能力.
- 为了实现个性化的阿齐思罗米辛剂量,以改善治疗结果.
主要方法:
- 使用模拟的药理动力学数据开发并验证了ML模型 (先验和后验).
- 使用了CatBoost算法,以患者特征 (体重,ALT) 和低谷度 (C0) 为预测因素.
- 在现实研究中使用统计和药理动力学方法评估模型准确性.
主要成果:
- 先验ML模型预测AUC0-24的平均绝对误差低于30%.
- 以后的ML模型,包括C0,在预测药理动力学目标的实现方面达到90.4%的准确性.
- 与标准指导方针相比,ML优化的剂量表明目标实现的可能性有所提高.
结论:
- 已建立的ML模型成功地预测了儿童的阿齐思罗米辛AUC0-24.
- 这些模型支持在治疗前和C0测量后进行个性化阿兹罗米辛剂量调整.
- 个性化剂量策略可以提高儿科肺炎的治疗疗效和安全性.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
06:19Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
Published on: October 11, 2024
相关概念视频
Analysis of Population Pharmacokinetic Data
Factors Affecting Drug Response: Overview
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Mechanistic Models: Compartment Models in Individual and Population Analysis
